Mei-Ling Nan Selected Research

RNA (Ribonucleic Acid)

1/2021

SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mei-Ling Nan Research Topics

Disease

5	Infections 01/2023 - 12/2020
4	Bites and Stings (Sting) 01/2023 - 01/2019
4	COVID-19 11/2022 - 12/2020
2	Vesicular Stomatitis 01/2022 - 12/2020
1	Cytokine Release Syndrome 11/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2019
1	Inflammation (Inflammations) 01/2019

Drug/Important Bio-Agent (IBA)

6	Antiviral Agents (Antivirals)IBA 01/2023 - 12/2020
4	Poly I-CIBA 01/2023 - 12/2020
4	InterferonsIBA 11/2022 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 11/2022
1	Viral ProteinsIBA 11/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Receptor for Advanced Glycation End ProductsIBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	HMGB1 Protein (HMG1)IBA 01/2019
1	CalreticulinIBA 01/2019
1	Pattern Recognition ReceptorsIBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	AntigensIBA 01/2019
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2019
1	Beclin-1IBA 01/2019
1	NLR ProteinsIBA 01/2019
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2019

Therapy/Procedure

1	Immunotherapy 01/2019